Although the informations about human genomics are comming to a great extent after the genome sequence revealed but variations among indevidual genes have remain elusive. More gemomics research are needed to completely execute the concept of personalized medicine.
I must sadly and repeatedly say that notorious Genetics is not surely working in the humans at all. Humans are only fighting against virus and bacteria.
Recently I have found that Down syndrome is caused by infection of Human adenovirus/HAdV (linear dsDNA virus, without envelope) and/or Human poliovirus/PV (+ssRNA, without envelope) during pregnancy (my unpublished result). Only three specimens have the Down syndrome cell adhesion molecule/CHD2/DSCAM (a membrane glycoprotein). Inducing power for Down syndrome cell adhesion molecule by HAdV-6 seems to be weak as compared to HAdV-2 and HAdV-40.
Hepatoma HepG2 has Down syndrome cell adhesion molecule/CHD2/DSCAM at 6.8 μg/mg cell protein. This cell has Packaging protein 3 (HAdV-2) at 0.2 μg/mg cell protein and Genome polyprotein (PV) at 5.1 μg/mg cell protein.
Healed hepatocyte HepG2 (cultured with fucoidan at 0.102 mg/mL for 3 days) has Down syndrome cell adhesion molecule/CHD2/DSCAM at 5.6 μg/mg cell protein. This cell has DNA polymerase (HAdV-40) at 1.3 μg/mg cell protein.
Serum of 1y girl (with biotin deficiency) has Down syndrome cell adhesion molecule/CHD2/DSCAM at 9.8 μg/mg serum protein. This serum has Maturation protein (HAdV-6) at 7.7 μg/mg serum protein.
Down syndrome cell adhesion molecule/CHD2/DSCAM shows up legulation of phosphorylation of proteins.
Thus, I would like to recommend the new quantitative proteomics PDMD method (please see files; HepG2 fucoidan and JMBT Alopecia).
Furthermore, HAdV seems to up regulate biotinidase (please see file; Brain-BIN Pig) and Brain-development proteins in addition to Down syndrome cell adhesion molecule/CHD2/DSCAM; as foolows; i.e.,
Liver tissue (with Pseudo-liver cancer) has HAdV at 2.0 μg/mg tissue protein. This tissue has Homeobox protein Hox-B7/Homeobox protein Hox-2C at 1.3, Semaphorin 3F at 0.76, Kidney biotinidase at 16.0, and Serum biotinidase at 22.7 μg/mg tissue protein, respectively. Total biotinidase and Brain-development protein becomes to be 40.76 μg/mg tissue protein.
LC tissue (with leprosy) has HAdV at 2.9 μg/mg tissue protein. This tissue has Cerebellin-1/Precerebellin at 1.4, Homeobox/POU domain protein RDC-1/Brain-specific homeobox/POU domain protein 3A at 1.6, Kidney biotinidase at 13.0, and Serum biotinidase at 23.0 μg/mg tissue protein, respectively. Total biotinidase and Brain-development protein becomes to be 39.0 μg/mg tissue protein.
HCC tissue (with PBC) has HAdV at 0.08 μg/mg tissue protein. This tissue has Synapsin-1/Synapsin I/Brain protein 4.1 at 3.4, Kidney biotinidase at 8.3, and Serum biotinidase at 11.5 μg/mg tissue protein, respectively. Total biotinidase and Brain-development protein becomes to be 23.2 μg/mg tissue protein.
LC tissue (named as No.6) has HAdV at 2.6 μg/mg tissue protein. This tissue has Homeobox protein HOX-B7/Homeobox protein Hox-2C; at 0.6, Synaptic functional regulator FMR1/Fragile X mental retardation 1 protein/Protein FMR-1 at 1.5, Serum biotinidase at 25.6, and Kidney biotinidase at 15.2 μg/mg tissue protein, respectively. Total biotinidase and Brain-development protein becomes to be 40.8 μg/mg tissue protein.
HCC tissue (No.6) has HAdV at 4.6 μg/mg tissue protein. This tissue has Possible global transcription activator SNF2L/ATP-dependent helicase SMARCA1 at 5.2, Synaptotagmin 1/P65 at 1.6, Tyrosine-protein kinase Lyn at 1.3, Serum biotinidase at 25.4, and Kidney biotinidase at 9.5 μg/mg tissue protein, respectively. Total biotinidase and Brain-development protein becomes to be 43.0 μg/mg tissue protein.